Top compounds associated with response to NUDT13


Feature Type Standardized
Nominal ANOVA
mRNA BRD1812 CTRPv2 pan-cancer AAC -0.088 0.01
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.09 0.02
mRNA BHG712 GDSC1000 pan-cancer AAC 0.071 0.02
mRNA BRD9647 CTRPv2 pan-cancer AAC -0.09 0.02
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.086 0.02
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.02
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC -0.068 0.02
mRNA ATRA FIMM pan-cancer AAC 0.34 0.02
mRNA pluripotin CTRPv2 pan-cancer AAC 0.083 0.02
mRNA Z-LLNle-CHO GDSC1000 pan-cancer AAC -0.11 0.02
Download CSV